Built Environment: Clinical Trials

4 trials of Built Environment, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed, 1 enrolling by invitation, 1 recruiting. 4 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable4Active not recruiting 1, Completed 1, Enrolling by invitation 1, Recruiting 1

Follow Built Environment: new trials by email Literature Review of Built Environment trials Research Report on Built Environment

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Environment on the Central and Peripheral Nervous System
Built environment, Natural environment - Rumination
Not applicableEnrolling by invitationUniversity of South Florida952025-02-142025-03-25
Effects of Walking in Greenspace and the Built Environment in Adults With Prediabetes: A Randomized Crossover Trial
Nature-based Walking, Built-environment/Commercial Walking - PreDiabetes, Heart Rate Variability (HRV)
Not applicableRecruitingUniversity of Minnesota2162024-06-062026-06-18
Cancer PRevention Through Enhanced EnvironMenT
Built Environment, Social Environment - Cancer Risk
Not applicableActive not recruitingUniversity of Alabama at Birmingham3002024-05-012026-03-11
Nature as a Buffer Among People With Chronic Pain
Natural Environment, Built Environment - Chronic Pain
Not applicableCompletedCornell University232016-07-012019-04-01

Conditions studied

Anxiety Disorders (1)  ·  Arrhythmia, Sinus (1)  ·  Chronic Pain (1)  ·  Neoplasms (1)  ·  Prediabetic State (1)  ·  Rumination Syndrome (1)

Sponsors

Cornell University (1)  ·  University of Alabama at Birmingham (1)  ·  University of Minnesota (1)  ·  University of South Florida (1)

Countries

United States (4)

Top investigators

Gabriela R Oates, PhD (1)  ·  Lori B Bateman, PhD (1)  ·  Mark Pereira, PhD (1)  ·  Nancy M Wells, PhD (1)

NIH funding

U54CA280770 (1)